BioCentury
ARTICLE | Clinical News

Prosigna Breast Cancer Prognostic Gene Signature Assay regulatory update

September 16, 2013 7:00 AM UTC

NanoString said FDA granted 510(k) clearance for Prosigna Breast Cancer Prognostic Gene Signature Assay for use as a prognostic indicator for distant recurrence-free survival at 10 years. The breast c...